Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
25
TIL Quote, Financials, Valuation and Earnings
Last price:
$11.39
Seasonality move
:
-13.64%
Day range:
$10.85 - $11.60
52-week range:
$10.70 - $42.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.65x
Volume:
54.9K
Avg. volume:
68.3K
1-year change:
-57.11%
Market cap:
$77.9M
Revenue:
--
EPS (TTM):
-$11.39
Analysts' Opinion
-
Consensus RatingInstil Bio, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $118.67, Instil Bio, Inc. has an estimated upside of 932.78% from its current price of $11.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $51.00 representing 100% downside risk from its current price of $11.49.
Fair Value
-
According to the consensus of 4 analysts, Instil Bio, Inc. has 932.78% upside to fair value with a price target of $118.67 per share.
TIL vs. S&P 500
-
Over the past 5 trading days, Instil Bio, Inc. has overperformed the S&P 500 by 0.08% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Instil Bio, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Instil Bio, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Instil Bio, Inc. reported revenues of --.
Earnings Growth
-
Instil Bio, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Instil Bio, Inc. reported earnings per share of -$2.01.
Enterprise value:
82.9M
EV / Invested capital:
0.40x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1.3M
Return On Assets:
-30.83%
Net Income Margin (TTM):
--
Return On Equity:
-50.54%
Return On Invested Capital:
-32.04%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$4.6M | -$3.9M | -$1.3M | -$900K | -$12K | |
| Operating Income | -$107.9M | -$57.4M | -$53.9M | -$11.3M | -$15M | |
| EBITDA | -$103.3M | -$53.5M | -$52.6M | -$10.4M | -$15M | |
| Diluted EPS | -$30.30 | -$11.56 | -$11.39 | -$3.54 | -$2.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $523.1M | $313.7M | $195.6M | $132.6M | $196.3M | |
| Total Assets | $647.4M | $532.7M | $340.3M | $272.6M | $211.8M | |
| Current Liabilities | $32.1M | $42.1M | $13.5M | $10.3M | $5.7M | |
| Total Liabilities | $46M | $122.2M | $106.2M | $96.2M | $91.3M | |
| Total Equity | $601.4M | $410.6M | $234M | $176.3M | $120.4M | |
| Total Debt | -- | $68.6M | $84.5M | $83.6M | $84.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$105.6M | -$58.5M | -$40.1M | -$20.1M | -$10.6M | |
| Cash From Investing | $60M | $54.9M | $30.7M | $19.8M | $8.4M | |
| Cash From Financing | $14.3M | $159K | $8.9M | $159K | $378K | |
| Free Cash Flow | -$139.2M | -$68.6M | -$40.1M | -$30.1M | -$10.6M | |
TIL
Sector
Market Cap
$77.9M
$28.4M
Price % of 52-Week High
26.85%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-6.22%
-1.32%
1-Year Price Total Return
-57.11%
-22.19%
Beta (5-Year)
--
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$11.86
200-day SMA
Sell
Level
$21.10
Bollinger Bands (100)
Sell
Level
15.6 - 27.16
Chaikin Money Flow
Sell
Level
-7M
20-day SMA
Sell
Level
$13.21
Relative Strength Index (RSI14)
Sell
Level
37.37
ADX Line
Sell
Level
38.23
Williams %R
Buy
Level
-82.5607
50-day SMA
Sell
Level
$16.46
MACD (12, 26)
Sell
Level
-1.66
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
5.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.899)
Sell
CA Score
(Annual)
Level (-0.6034)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.2598)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Stock Forecast FAQ
In the current month, TIL has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The TIL average analyst price target in the past 3 months is $118.67.
-
Where Will Instil Bio, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Instil Bio, Inc. share price will rise to $118.67 per share over the next 12 months.
-
What Do Analysts Say About Instil Bio, Inc.?
Analysts are divided on their view about Instil Bio, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Instil Bio, Inc. is a Sell and believe this share price will drop from its current level to $51.00.
-
What Is Instil Bio, Inc.'s Price Target?
The price target for Instil Bio, Inc. over the next 1-year time period is forecast to be $118.67 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is TIL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Instil Bio, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TIL?
You can purchase shares of Instil Bio, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Instil Bio, Inc. shares.
-
What Is The Instil Bio, Inc. Share Price Today?
Instil Bio, Inc. was last trading at $11.39 per share. This represents the most recent stock quote for Instil Bio, Inc.. Yesterday, Instil Bio, Inc. closed at $11.49 per share.
-
How To Buy Instil Bio, Inc. Stock Online?
In order to purchase Instil Bio, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TIL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TIL
Sector
P/E ratio
--
23.66x
PEG ratio
--
-0.01x
P/B ratio
0.65x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
TIL
Sector
Revenue growth
--
4.85%
Earnings growth
43.17%
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$3.04
-$0.20
Profitability
TIL
Sector
Profitability FY 2024
-$3.6M
$3.6M
Return on invested capital
-32.04%
-30.98%
Return on assets
-30.83%
-27.62%
Return on equity
-50.54%
-36.69%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Feb
12
Balance Sheet
TIL
Sector
Total cash
$79.9M
$27.2M
Short term investments
$104.5M
$25.7M
Total assets
$264.8M
$79.9M
Long term debt
$84.6M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
